Tanke Financial Statements From 2010 to 2024
| TNBI Stock | USD 0.01 0.00 0.00% |
Check Tanke Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tanke Biosciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . Tanke financial statements analysis is a perfect complement when working with Tanke Biosciences Valuation or Volatility modules.
Tanke |
Tanke Biosciences Company Return On Equity Analysis
Tanke Biosciences' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Tanke Biosciences Return On Equity | -0.1 |
Most of Tanke Biosciences' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tanke Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Tanke Biosciences has a Return On Equity of -0.1039. This is 107.17% lower than that of the Financial Services sector and significantly lower than that of the Shell Companies industry. The return on equity for all United States stocks is 66.48% lower than that of the firm.
Tanke Biosciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Tanke Biosciences's current stock value. Our valuation model uses many indicators to compare Tanke Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tanke Biosciences competition to find correlations between indicators driving Tanke Biosciences's intrinsic value. More Info.Tanke Biosciences is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Tanke Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Tanke Biosciences' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Tanke Biosciences Financial Statements
Investors use fundamental indicators, such as Tanke Biosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Although Tanke Biosciences' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Tanke Biosciences Corporation, through its subsidiaries, develops, produces, markets, and sells animal nutrition and feed additive products. Tanke Biosciences Corporation was founded in 1989 and is headquartered in Guangzhou, the Peoples Republic of China. TANKE BIOSCIENCES operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 130 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Tanke Pink Sheet
Tanke Biosciences financial ratios help investors to determine whether Tanke Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tanke with respect to the benefits of owning Tanke Biosciences security.